https://www.biospace.com/optinose-reports-second-quarter-2024-financial-results-and-recent-operational-highlights
Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights - BioSpace
2024 financial resultssecond quarter
https://www.finder.com/stock-trading/buy-optinose-stock
How to Buy OptiNose Stock (OPTN)
Aug 4, 2021 - We explain how to buy OptiNose stock, compare the best stock trading platforms and use a detailed analysis to learn about (OPTN).
how to buyoptinosestockoptn
https://www.fool.com/earnings/call-transcripts/2019/05/09/optinose-inc-optn-q1-2019-earnings-call-transcript.aspx
OptiNose, Inc. (OPTN) Q1 2019 Earnings Call Transcript | The Motley Fool
Jun 21, 2019 - OPTN earnings call for the period ending March 31, 2019.
earnings call transcriptq1 2019the motleyoptinoseinc
https://www.biospace.com/optinose-announces-ceo-transition-and-business-updateramy-mahmoud-md-mph-appointed-ceo-and-to-the-board-of-directors
Optinose Announces CEO Transition and Business Update - BioSpace
Jan 31, 2023 - Optinose today announced that Peter Miller has stepped down as Chief Executive Officer and Board member, and that Ramy Mahmoud, MD, MPH has been appointed as...
business updateoptinoseannouncesceotransition
https://optinose.com/
Home | Optinose
Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose,...
optinose
https://www.globenewswire.com/news-release/2024/12/26/3001923/0/en/Optinose-Announces-1-for-15-Reverse-Stock-Split.html
Optinose Announces 1-for-15 Reverse Stock Split
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and...
optinoseannounces1reversestock
https://www.einpresswire.com/article/451097341/optinose-announces-closing-of-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-common-shares
Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to...
Jun 11, 2018 - OptiNose, Inc. (NASDAQ:OPTN), announced today the closing of its underwritten public offering of 5,750,000 of its common shares at a price to the public of